Free Trial

SurgePays (SURG) Competitors

$1.65
+0.03 (+1.85%)
(As of 01:24 PM ET)

SURG vs. EDAP, KRMD, FONR, MGRM, SRTS, PDEX, MODD, HYPR, CTSO, and MLSS

Should you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include Edap Tms (EDAP), KORU Medical Systems (KRMD), FONAR (FONR), Monogram Orthopaedics (MGRM), Sensus Healthcare (SRTS), Pro-Dex (PDEX), Modular Medical (MODD), Hyperfine (HYPR), Cytosorbents (CTSO), and Milestone Scientific (MLSS). These companies are all part of the "medical equipment" industry.

SurgePays vs.

SurgePays (NASDAQ:SURG) and Edap Tms (NASDAQ:EDAP) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations, risk and community ranking.

Edap Tms received 178 more outperform votes than SurgePays when rated by MarketBeat users. However, 68.98% of users gave SurgePays an outperform vote while only 62.41% of users gave Edap Tms an outperform vote.

CompanyUnderperformOutperform
SurgePaysOutperform Votes
169
68.98%
Underperform Votes
76
31.02%
Edap TmsOutperform Votes
347
62.41%
Underperform Votes
209
37.59%

SurgePays has higher revenue and earnings than Edap Tms. Edap Tms is trading at a lower price-to-earnings ratio than SurgePays, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SurgePays$112.99M0.28$20.62M$1.151.41
Edap Tms$62.05M1.88-$22.92M-$0.54-5.83

6.9% of SurgePays shares are held by institutional investors. Comparatively, 62.7% of Edap Tms shares are held by institutional investors. 29.4% of SurgePays shares are held by insiders. Comparatively, 0.2% of Edap Tms shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

SurgePays has a net margin of -1.36% compared to Edap Tms' net margin of -31.68%. SurgePays' return on equity of -3.97% beat Edap Tms' return on equity.

Company Net Margins Return on Equity Return on Assets
SurgePays-1.36% -3.97% -2.91%
Edap Tms -31.68%-36.41%-22.25%

SurgePays has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, Edap Tms has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500.

SurgePays currently has a consensus price target of $9.00, indicating a potential upside of 455.56%. Edap Tms has a consensus price target of $14.00, indicating a potential upside of 344.44%. Given SurgePays' higher probable upside, equities research analysts clearly believe SurgePays is more favorable than Edap Tms.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SurgePays
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Edap Tms
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Edap Tms had 2 more articles in the media than SurgePays. MarketBeat recorded 5 mentions for Edap Tms and 3 mentions for SurgePays. Edap Tms' average media sentiment score of 1.23 beat SurgePays' score of 0.09 indicating that Edap Tms is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SurgePays
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Edap Tms
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

SurgePays beats Edap Tms on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SURG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SURG vs. The Competition

MetricSurgePaysTelephone communication, except radio IndustryComputer SectorNASDAQ Exchange
Market Cap$31.45M$23.96B$21.79B$8.26B
Dividend YieldN/A3.38%2.74%4.09%
P/E Ratio1.4125.33263.9718.87
Price / Sales0.285.16576.9172.51
Price / Cash1.158.7731.0531.81
Price / Book0.962.816.854.54
Net Income$20.62M$815.43M$660.98M$224.23M
7 Day Performance9.46%1.94%2.00%5.57%
1 Month Performance-21.74%5.69%2.48%8.85%
1 Year Performance-65.24%20.12%17.31%12.05%

SurgePays Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EDAP
Edap Tms
3.6235 of 5 stars
3.62 / 5 stars
$3.15
-2.8%
$14.00
+344.4%
-54.1%$116.88M$62.05M-5.83230News Coverage
Positive News
KRMD
KORU Medical Systems
3.4165 of 5 stars
3.42 / 5 stars
$2.51
+5.0%
$3.33
+32.8%
-5.6%$115.08M$28.52M-8.9680News Coverage
Positive News
FONR
FONAR
2.8151 of 5 stars
2.82 / 5 stars
$17.55
+2.2%
N/A+12.9%$111.06M$102.72M11.25480Analyst Downgrade
Short Interest ↓
News Coverage
Positive News
High Trading Volume
MGRM
Monogram Orthopaedics
0.4842 of 5 stars
0.48 / 5 stars
$3.23
-1.2%
N/A+8.4%$102.29M$364,999.00-6.4628Gap Up
High Trading Volume
SRTS
Sensus Healthcare
4.1771 of 5 stars
4.18 / 5 stars
$5.99
-2.1%
$10.00
+66.9%
+119.4%$98.18M$24.41M20.6640Positive News
PDEX
Pro-Dex
2.3478 of 5 stars
2.35 / 5 stars
$24.75
-12.8%
$30.00
+21.2%
+54.7%$84.62M$53.84M42.67140Gap Up
High Trading Volume
MODD
Modular Medical
3.6431 of 5 stars
3.64 / 5 stars
$2.27
flat
$4.25
+87.2%
+72.0%$73.86MN/A-2.9120High Trading Volume
HYPR
Hyperfine
2.7854 of 5 stars
2.79 / 5 stars
$1.00
-2.9%
$1.43
+42.5%
-51.7%$71.95M$11.94M-1.69190
CTSO
Cytosorbents
1.7976 of 5 stars
1.80 / 5 stars
$1.32
+6.5%
$2.00
+51.5%
-33.3%$71.68M$32.93M-2.24220Analyst Forecast
MLSS
Milestone Scientific
0 of 5 stars
0.00 / 5 stars
$0.91
-2.2%
N/A-9.2%$70.14M$8.42M-9.0830Analyst Forecast

Related Companies and Tools


This page (NASDAQ:SURG) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners